Publications (37) Saida Ortolano . publications

2024

  1. Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers

    Translational Research, Vol. 269, pp. 47-63

  2. Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  3. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. Fabry Disease and Central Nervous System Involvement: From Big to Small, from Brain to Synapse

    International journal of molecular sciences, Vol. 24, Núm. 6

  2. Morphological Hallmarks of Classical Fabry Disease: An Ultrastructural Study in a Large Spanish Family

    Journal of Clinical Medicine, Vol. 12, Núm. 17

  3. Programming an Enhanced Uptake and the Intracellular Fate of Magnetic Microbeads

    Advanced Healthcare Materials, Vol. 12, Núm. 30

  4. Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

2022

  1. Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients

    International Journal of Molecular Sciences, Vol. 23, Núm. 17

2021

  1. Systemic Treatment of Fabry Disease Using a Novel AAV9 Vector Expressing α-Galactosidase A

    Molecular Therapy - Methods and Clinical Development, Vol. 20, pp. 1-17

  2. The new pharmacological chaperones pbxs increase α-galactosidase a activity in fabry disease cellular models

    Biomolecules, Vol. 11, Núm. 12

  3. Therapeutic approaches in lysosomal storage diseases

    Biomolecules, Vol. 11, Núm. 12

2018

  1. Fabry disease in the Spanish population: Observational study with detection of 77 patients

    Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1

  2. Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases

    Ageing Research Reviews, Vol. 47, pp. 214-277

2017

  1. Newborn screening for Fabry disease in the north-west of Spain

    European Journal of Pediatrics, Vol. 176, Núm. 8, pp. 1075-1081

2016

  1. Frailty in mouse ageing: A conceptual approach

    Mechanisms of Ageing and Development, Vol. 160, pp. 34-40

  2. Small molecules: Substrate inhibitors, chaperones, stop-codon read through, and beyond

    Journal of Inborn Errors of Metabolism and Screening, Vol. 4

2014

  1. Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease

    Molecular Brain, Vol. 7, Núm. 1

  2. Treatment of lysosomal storage diseases: Recent patents and future strategies

    Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 8, Núm. 1, pp. 9-25

2013

  1. Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin 3 gene

    Brain, Vol. 136, Núm. 5, pp. 1508-1517

  2. tPA in the central nervous system: Relations between tPA and cell surface LRPs

    Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 7, Núm. 1, pp. 65-76